Skip to content
OpenCapital
Get started

USANA Health Sciences USNA Operating lease right-of-use asset amortization

Operating lease right-of-use asset amortization at other companies

Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
——
Evommune logo
Evommune EVMN
——
SMP
The Simply Good Foods CompanySMPL
——

Other financials

Income statement

See full
Revenue$250.2M+0.3%
Gross profit$190.8M-3.2%
Operating income$13.9M-11.5%
Net income$7.5M-20.1%
EPS (diluted)$0.41-16.3%

Balance sheet

See full
Cash & equivalents$165.7M-9.2%
Total debt$18.0M+10.8%
Total equity$543.6M+2.6%
Total assets$739.0M-1.0%

Cash flow

See full
Operating cash flow$9.8M-37.0%
CapEx$2.6M-5.6%
Free cash flow$7.1M-43.9%

Valuation

See full
Market cap$363.35M-36.1%
P/E18.1×+7.8×
P/S0.4×-0.3×

Profitability

See full
Gross margin77.6%-3.0pp
Operating margin3.8%-2.7pp
Net margin1.9%-4.4pp
FCF margin5.7%-1.1pp

Returns & leverage

See full
Return on equity3.2%-7.6pp
Debt / equity0×0.0×
Current ratio2.5×+0.5×

Where this comes from

Reported directly by USANA Health Sciences in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.

The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's operating lease right-of-use asset amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is USANA Health Sciences's operating lease right-of-use asset amortization?
USANA Health Sciences (USNA) reported operating lease right-of-use asset amortization of $1.51M in Q1 2026.
How has USANA Health Sciences's operating lease right-of-use asset amortization changed year-over-year?
USANA Health Sciences's operating lease right-of-use asset amortization decreased by 20.7% year-over-year, from $1.91M to $1.51M.
What is the long-term trend for USANA Health Sciences's operating lease right-of-use asset amortization?
Over 4 years (2021 to 2025), USANA Health Sciences's operating lease right-of-use asset amortization has grown at a -6.0% compound annual growth rate (CAGR), from $9.16M to $7.14M.